Key result
Percutaneous cardiopulmonary support for ~300 hours reverses cardiogenic shock in fulminant myocarditis.
Why the study?
Acute fulminant myocarditis can lead to cardiac standstill requiring advanced mechanical support, but reports on long-term percutaneous cardiopulmonary support are limited.
Key points are not available for this paper at this time.
Population
A 41-year-old man with acute fulminant myocarditis
Design
Case report
Follow-up
302 hours of percutaneous cardiopulmonary support
Prolonged percutaneous support may be feasible in fulminant myocarditis; hypothesis-generating and requires prospective confirmation before practice change.
We report the case of a 41-year-old man with acute fulminant myocarditis. The patient went into cardiac standstill immediately after admission and was placed on a percutaneous cardiopulmonary support system. The system remained in place for 302 h, after which the patient recovered from cardiogenic shock without complications and has returned to normal life.
No takes yet. Share an insight, caveat, or question.
Morishima et al. (1994) studied this question. Percutaneous cardiopulmonary support maintained for 302 hours successfully rescued a patient with acute fulminant myocarditis, resolving cardiogenic shock without complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: